NO865079L - Fremgangsmaate for fremstilling av stabiliserte humanvevplasminogenaktivatorpreparater. - Google Patents

Fremgangsmaate for fremstilling av stabiliserte humanvevplasminogenaktivatorpreparater.

Info

Publication number
NO865079L
NO865079L NO865079A NO865079A NO865079L NO 865079 L NO865079 L NO 865079L NO 865079 A NO865079 A NO 865079A NO 865079 A NO865079 A NO 865079A NO 865079 L NO865079 L NO 865079L
Authority
NO
Norway
Prior art keywords
plasminogen activator
procedure
preparation
stabilized human
activator preparations
Prior art date
Application number
NO865079A
Other languages
English (en)
Other versions
NO168988B (no
NO168988C (no
NO865079D0 (no
Inventor
William Franklin Bennett
Stuart Elliot Builder
Larry Alan Gatlin
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25205495&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO865079(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of NO865079D0 publication Critical patent/NO865079D0/no
Publication of NO865079L publication Critical patent/NO865079L/no
Publication of NO168988B publication Critical patent/NO168988B/no
Publication of NO168988C publication Critical patent/NO168988C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO865079A 1985-12-17 1986-12-16 Anvendelse av en argininiumholdig buffer til formulering av stabile farmasoeytiske preparater inneholdende humanvevplasminogenaktivator NO168988C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/811,081 US4777043A (en) 1985-12-17 1985-12-17 Stabilized human tissue plasminogen activator compositions

Publications (4)

Publication Number Publication Date
NO865079D0 NO865079D0 (no) 1986-12-16
NO865079L true NO865079L (no) 1987-06-18
NO168988B NO168988B (no) 1992-01-20
NO168988C NO168988C (no) 1992-04-29

Family

ID=25205495

Family Applications (1)

Application Number Title Priority Date Filing Date
NO865079A NO168988C (no) 1985-12-17 1986-12-16 Anvendelse av en argininiumholdig buffer til formulering av stabile farmasoeytiske preparater inneholdende humanvevplasminogenaktivator

Country Status (23)

Country Link
US (2) US4777043A (no)
EP (1) EP0228862B1 (no)
JP (2) JPH0714886B2 (no)
KR (1) KR950010322B1 (no)
AT (1) ATE79273T1 (no)
AU (1) AU600246B2 (no)
DD (1) DD255477A5 (no)
DE (2) DE3642960A1 (no)
DK (1) DK174203B1 (no)
ES (1) ES2044840T3 (no)
FI (1) FI88873C (no)
FR (1) FR2591485B1 (no)
GB (1) GB2184354B (no)
GR (1) GR3006078T3 (no)
HU (1) HU200101B (no)
IE (1) IE59060B1 (no)
IL (1) IL80904A (no)
MY (1) MY102185A (no)
NO (1) NO168988C (no)
NZ (1) NZ218612A (no)
PH (1) PH24716A (no)
PT (1) PT83933B (no)
ZA (1) ZA869457B (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE83153T1 (de) * 1985-09-10 1992-12-15 Eisai Co Ltd Einen gewebe-plasminogen-aktivator enthaltende zusammensetzung.
JPH0672105B2 (ja) * 1985-10-02 1994-09-14 持田製薬株式会社 血栓溶解剤及びその製法
US5453363A (en) * 1985-10-23 1995-09-26 Boehringer Mannheim Gmbh Process for the activation of t-PA or Ing after genetic expression in prokaryotes
US5034225A (en) * 1985-12-17 1991-07-23 Genentech Inc. Stabilized human tissue plasminogen activator compositions
JP2708749B2 (ja) * 1987-08-10 1998-02-04 エーザイ株式会社 修飾型ｔＰＡ含有注射用組成物
ES2045167T5 (es) * 1987-10-23 1996-07-01 Centre Regional De Transfusion Preparacion de concentrado de factor ix humano de elevada pureza y de otras proteinas plasmaticas.
US4898826A (en) * 1987-12-10 1990-02-06 Invitron Corporation Method to solubilize tissue plasminogen activator
HU206367B (en) * 1988-04-30 1992-10-28 Sandoz Ag Process for producing acid addition salts of steroid carboxylic acid-amidated taurine and glycine, as well as pharmaceutical compositions comprising such salts
US4980165A (en) * 1989-01-27 1990-12-25 Genetics Institute, Inc. Pharmaceutical formulations of plasminogen activator proteins
DE3903581A1 (de) * 1989-02-07 1990-08-16 Boehringer Mannheim Gmbh Gewebs-plasminogenaktivator-derivat
US6207151B1 (en) * 1989-09-21 2001-03-27 Mitsui Chemicals Inc. Aqueous solution of t-PA
JP2520975B2 (ja) * 1989-09-21 1996-07-31 三井東圧化学株式会社 組織プラスミノ―ゲンアクチベ―タ―若しくはその誘導体を含有する血栓溶解剤
DE3942143A1 (de) * 1989-12-20 1991-06-27 Boehringer Mannheim Gmbh T-pa pro stabilisierung
DE3942144A1 (de) * 1989-12-20 1991-06-27 Boehringer Mannheim Gmbh Stabilisierung von k1k2p pro
DE3942142A1 (de) * 1989-12-20 1991-06-27 Boehringer Mannheim Gmbh Stabilisierung von glykosyliertem t-pa
DE3942141A1 (de) * 1989-12-20 1991-06-27 Boehringer Mannheim Gmbh K2p pro-stabilisierung
DE3942145A1 (de) * 1989-12-20 1991-06-27 Boehringer Mannheim Gmbh T-pa-solubilisierung
US5358708A (en) * 1993-01-29 1994-10-25 Schering Corporation Stabilization of protein formulations
US5656730A (en) * 1995-04-07 1997-08-12 Enzon, Inc. Stabilized monomeric protein compositions
DE19606551C2 (de) * 1996-02-22 2000-06-08 Basotherm Gmbh rt-PA zur Prävention des Nachstars nach Kataraktoperation
US5972912A (en) * 1998-12-17 1999-10-26 S.P. Pharmaceuticals Method for lyophilizing ifosfamide
AU6558400A (en) * 1999-08-17 2001-03-13 Novo Nordisk A/S Stabilisation of freeze-dried cake
US6586574B1 (en) 1999-08-17 2003-07-01 Nn A/S Stabilization of freeze-dried cake
JP4659320B2 (ja) * 1999-11-04 2011-03-30 ジェネンテック， インコーポレイテッド プラスミノーゲン活性化因子の逆相ｈｐｌｃアッセイ
EP1273306A4 (en) * 2000-03-31 2005-06-22 Kirin Brewery POWDER PREPARATION FOR TRANSMUCOSAL ADMINISTRATION CONTAINING A POLYMERIC FORM OF AN ACTIVE SUBSTANCE AND HAVING AN IMPROVED STORAGE STABILITY
US20030077682A1 (en) * 2001-09-07 2003-04-24 Hung Paul Porwen Human tissue urokinase type plasminogen activator formulation
US20110179558A1 (en) * 2009-07-29 2011-07-28 International Enviroguard Systems, Inc. Breathable Protective Fabric and Garment
JP6649246B2 (ja) * 2013-03-14 2020-02-19 アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ タンパク質の徐放性送達の組成物及び製造プロセス中のタンパク質の安定化方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK98833C (da) * 1961-04-25 1964-05-25 Novo Terapeutisk Labor As Fremgangsmåde til stabilisering af terapeutisk anvendelige plasminopløsninger.
EP0112940B1 (en) * 1982-12-30 1986-10-15 Kowa Company, Ltd. Method of producing a tissue plasminogen activator and composition comprising same
JPS59196824A (ja) * 1983-04-21 1984-11-08 Kowa Co 吸着防止剤
EP0156169B1 (en) * 1984-02-29 1991-12-18 Asahi Kasei Kogyo Kabushiki Kaisha An aqueous solution of a tissue plasminogen activator dissolved therein at an increased concentration and a method
IE58574B1 (en) * 1985-04-22 1993-10-06 Genentech Inc Human tissue plasminogen activator mutants, methods and intermediates therefor, and compositions using such mutants
US4929444A (en) * 1985-05-28 1990-05-29 Burroughs Wellcome Co. Low pH pharmaceutical formulation containing t-PA
AU569429B2 (en) * 1985-05-28 1988-01-28 Wellcome Foundation Limited, The Aqueous acidic tissue plasminogen activator parenternal formulation
ZW14486A1 (en) * 1985-07-29 1986-10-22 Smithkline Beckman Corp Pharmaceutical dosage unit
ATE83153T1 (de) * 1985-09-10 1992-12-15 Eisai Co Ltd Einen gewebe-plasminogen-aktivator enthaltende zusammensetzung.
JPH0672105B2 (ja) * 1985-10-02 1994-09-14 持田製薬株式会社 血栓溶解剤及びその製法
DE3537708A1 (de) * 1985-10-23 1987-04-23 Boehringer Mannheim Gmbh Verfahren zur aktivierung von t-pa nach expression in prokaryonten
JPS62120321A (ja) * 1985-11-20 1987-06-01 Eisai Co Ltd ｔＰＡ含有医薬組成物
JPS62283932A (ja) * 1986-05-29 1987-12-09 Green Cross Corp:The 組織プラスミノ−ゲンアクチベ−タの乾燥製剤

Also Published As

Publication number Publication date
IL80904A (en) 1992-01-15
DE3686410D1 (de) 1992-09-17
MY102185A (en) 1992-04-30
PH24716A (en) 1990-10-01
NZ218612A (en) 1989-07-27
NO168988B (no) 1992-01-20
US4908205A (en) 1990-03-13
AU6661086A (en) 1987-06-18
ATE79273T1 (de) 1992-08-15
FR2591485B1 (fr) 1989-07-28
EP0228862A2 (en) 1987-07-15
DK174203B1 (da) 2002-09-16
PT83933A (en) 1987-01-01
GB8629981D0 (en) 1987-01-28
DE3686410T2 (de) 1993-02-18
GR3006078T3 (no) 1993-06-21
NO168988C (no) 1992-04-29
FI865159A0 (fi) 1986-12-17
KR870005647A (ko) 1987-07-06
HUT42955A (en) 1987-09-28
IE863279L (en) 1987-06-17
JPS62164632A (ja) 1987-07-21
DK605786D0 (da) 1986-12-16
JPH07173076A (ja) 1995-07-11
FI88873B (fi) 1993-04-15
GB2184354A (en) 1987-06-24
FI88873C (fi) 1993-07-26
IE59060B1 (en) 1993-12-15
EP0228862B1 (en) 1992-08-12
ES2044840T3 (es) 1994-01-16
JPH0714886B2 (ja) 1995-02-22
IL80904A0 (en) 1987-03-31
AU600246B2 (en) 1990-08-09
FI865159L (fi) 1987-06-18
DE3642960A1 (de) 1987-06-19
HU200101B (en) 1990-04-28
FR2591485A1 (fr) 1987-06-19
DK605786A (da) 1987-06-18
KR950010322B1 (ko) 1995-09-14
ZA869457B (en) 1988-08-31
US4777043A (en) 1988-10-11
GB2184354B (en) 1990-04-11
EP0228862A3 (en) 1988-09-28
PT83933B (pt) 1989-01-17
DD255477A5 (de) 1988-04-06
NO865079D0 (no) 1986-12-16

Similar Documents

Publication Publication Date Title
NO865079L (no) Fremgangsmaate for fremstilling av stabiliserte humanvevplasminogenaktivatorpreparater.
ZA895090B (en) Novel benzopyran derivatives,processes for their preparation and their use and preparations containing the compounds
NO862096L (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater inneholdende vevsplasminogenaktivator.
NO171344C (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater inneholdende vevsplasminogenaktivator
PL268927A1 (en) Method of obtaining novel derivatives of benzimidazole
NO921382D0 (no) Amidinofenylalaninderivater, samt fremstilling, anvendelse og preparater inneholdende forbindelsene
NO900297D0 (no) Fremgangsmaate for fremstilling av vaeskeformige preparaterinneholdende piperidinoalkanolderivater.
NO164972C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive gem-dihalo-1,8-diamino-4-aza-octaner.
SE8503447L (sv) Farmaceutiska och kosmetiska kompositioner, innehallande dihydroxi-1,8-fenyl-10-antron-9 som verksam bestandsdel, samt sett att framstella den verksamma foreningen
SE8503513L (sv) Farmaceutiska och kosmetiska kompositioner, vilka som verksam bestandsdel innehaller acetyl-10-triacetoxi-1,8,9-antracen
NO891678L (no) Fremgangsmaate for fremstilling av terapeutisk aktive etanolamin-derivater.
NO890502D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive etanolamin-derivater.
AU2798884A (en) 2-alkylthio-1-aminoalkyl-2-pyroline-3-carbonitriles
NO903705D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n,n-disubstituerte arylcykloalkylaminer.
ES8706441A1 (es) Procedimiento para preparar una composicion farmaceutica a base de sulpirida y un progestageno.
NO890506D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kloranilin-derivater.
NO891677D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive fenetanolamin-derivater.

Legal Events

Date Code Title Description
MK1K Patent expired